SJS Investment Consulting’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.65K Buy
1,008
+531
+111% +$1.84K ﹤0.01% 2083
2026
Q2
$1.63K Buy
477
+282
+145% +$938 ﹤0.01% 1854
2026
Q1
$699 Buy
+195
New +$775 ﹤0.01% 1606

Other funds holding RCKT

SJS Investment Consulting's RCKT Position: Q3 2026 in Review

SJS Investment Consulting increased its Rocket Pharmaceuticals (RCKT) stake by 111% in Q3 2026, buying an estimated $1.84K and bringing the position to 1,008 shares worth $2.65K. The position accounts for ﹤0.01% of the portfolio, ranked #2083.

SJS Investment Consulting first reported a position in RCKT in Q1 2026 and has held it in 3 quarters since. 175 funds tracked by Wall St. Rank hold RCKT as of Q3 2026.

  • SJS Investment Consulting held 1,008 shares of Rocket Pharmaceuticals worth $2.65K as of Q3 2026.
  • SJS Investment Consulting bought 531 Rocket Pharmaceuticals shares in Q3 2026, an estimated $1.84K.
  • Rocket Pharmaceuticals made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #2083 holding.
  • SJS Investment Consulting first reported a position in Rocket Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • 175 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2026.

Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.